Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Department of Veterans Affairs |
---|---|
Information provided by: | Department of Veterans Affairs |
ClinicalTrials.gov Identifier: | NCT00414401 |
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal.
Condition | Intervention |
---|---|
Heart Failure, Congestive |
Behavioral: Clinical Reminder |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Clinical Reminders in Test Reports to Improve Guideline Compliance |
Estimated Enrollment: | 1500 |
Study Start Date: | May 2001 |
Study Completion Date: | June 2006 |
Arms | Assigned Interventions |
---|---|
1 | Behavioral: Clinical Reminder |
Background:
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal.
Objectives:
To determine if a reminder attached to the echocardiography report would increase the use of beta-blockers among patients with depressed left ventricular function.
Methods:
We are randomizing consecutive patients undergoing echocardiography at one of three VA echocardiography laboratories with reduced left ventricular ejection fraction (<40%) and no echocardiographic contraindication to beta-blockers (e.g. aortic stenosis) to a reminder for use of beta-blockers or to no reminder. The reminder gives starting doses for two commonly used beta-blockers (carvedilol and metoprolol). Patients are excluded from the analysis if they leave the health care system or die within three months of randomization. The primary outcome is a prescription for a beta-blocker between three and nine months following echocardiography
Status:
The project is complete.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Those undergoing echocardiography at one of the participating laboratories with an ejection fraction < 45%.
Exclusion Criteria:
aortic stenosis, mitral stenosis
United States, California | |
VA Palo Alto Health Care System HSR&D COE | |
Palo Alto, California, United States, 94304-1207 |
Principal Investigator: | Paul A. Heidenreich, MD | VA Palo Alto Health Care System |
Responsible Party: | Department of Veterans Affairs ( Heidenreich, Paul - Principal Investigator ) |
Study ID Numbers: | IIR 01-108 |
Study First Received: | December 19, 2006 |
Last Updated: | April 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00414401 |
Health Authority: | United States: Federal Government |
Heart Failure Heart Diseases |
Cardiovascular Diseases |